Mitotech S.A, a Luxembourg-based clinical-stage biotechnology company, announced that its Chief Scientific Officer, Dr Maxim Skulachev, will give a full presentation at the Mitochondria-Targeted Drug Development conference, taking place virtually in February 2022.
February 24, 2022
· 1 min read